Page last updated: 2024-09-05

tolvaptan and angiotensin ii

tolvaptan has been researched along with angiotensin ii in 2 studies

Compound Research Comparison

Studies
(tolvaptan)
Trials
(tolvaptan)
Recent Studies (post-2010)
(tolvaptan)
Studies
(angiotensin ii)
Trials
(angiotensin ii)
Recent Studies (post-2010) (angiotensin ii)
96717278638,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomytolvaptan (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dhalla, NS; Rehsia, NS1
Chang, WH; Lu, HY; Shih, CC; Wu, TC1

Reviews

1 review(s) available for tolvaptan and angiotensin ii

ArticleYear
Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure.
    Heart failure reviews, 2010, Volume: 15, Issue:1

    Topics: Angiotensin II; Animals; Antidiuretic Agents; Antihypertensive Agents; Benzazepines; Biomarkers; Bosentan; Catecholamines; Drug Therapy, Combination; Endothelin-1; Heart Failure; Humans; Peptides, Cyclic; Renin-Angiotensin System; Sulfonamides; Sympathetic Nervous System; Tolvaptan; Treatment Outcome; Vasopressins

2010

Other Studies

1 other study(ies) available for tolvaptan and angiotensin ii

ArticleYear
Tolvaptan reduces angiotensin II-induced experimental abdominal aortic aneurysm and dissection.
    Vascular pharmacology, 2022, Volume: 144

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Disease Models, Animal; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Knockout, ApoE; Tolvaptan

2022